Marshall Wace North America’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$18.1M Buy
431,024
+415,965
+2,762% +$18M 0.08% 249
2021
Q2
$667K Buy
+15,059
New +$696K ﹤0.01% 1109
2020
Q4
Sell
-71,314
Closed -$2.05M 1357
2020
Q3
$2.05M Sell
71,314
-122,209
-63% -$3.44M 0.01% 578
2020
Q2
$5.18M Buy
193,523
+156,289
+420% +$4.07M 0.03% 365
2020
Q1
$875K Buy
+37,234
New +$1.02M 0.01% 637
2019
Q3
Sell
-121,227
Closed -$3.58M 1343
2019
Q2
$3.58M Buy
+121,227
New +$3.26M 0.02% 430

Other funds holding CTVA

Marshall Wace North America's CTVA Position: Q3 2021 in Review

Marshall Wace North America increased its Corteva (CTVA) stake by 2,762% in Q3 2021, buying an estimated $18M and bringing the position to 431,024 shares worth $18.1M. The position accounts for 0.08% of the portfolio, ranked #249.

Marshall Wace North America first reported a position in CTVA in Q2 2019 and has held it in 6 quarters since. 1,038 funds tracked by Wall St. Rank hold CTVA as of Q3 2021.

  • Marshall Wace North America held 431,024 shares of Corteva worth $18.1M as of Q3 2021.
  • Marshall Wace North America bought 415,965 Corteva shares in Q3 2021, an estimated $18M.
  • Corteva made up 0.08% of Marshall Wace North America's portfolio in Q3 2021, its #249 holding.
  • Marshall Wace North America first reported a position in Corteva in Q2 2019 and has held it in 6 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Corteva as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.